There is now a cap on the high margins earned by distributors, but where pharma firms themselves charge exorbitant rates, the intervention offers little. India's NPPA caps trade margins on anti-cancer drugs to reduce costs significantly, aiming for annual savings of ₹2,500 crore. Find out how this affects prices for essential medications. As revised prices of non-scheduled anti-cancer drugs take effect from November 9, the pharma secretary explains why the government stepped.